Table 2.
Results from the linear regression models examining the relationship between metabolites measured at the 12 day assessment and cognitive and somatic symptom burden at the 3 month assessment.
| HBI cognitive symptoms | HBI somatic symptoms | |||
|---|---|---|---|---|
| B (SE) = | p = | B (SE) = | p = | |
| tNAA | − 0.624 (0.68) | 0.358 | 0.102 (0.38) | 0.786 |
| tCr | 2.095 (1.0) | 0.037 | 0.491 (0.55) | 0.376 |
| tCho | − 3.177 (2.0) | 0.113 | − 0.529 (1.12) | 0.636 |
| Glx | − 0.178 (0.23) | 0.43 | − 0.049 (0.13) | 0.699 |
| mI | − 0.652 (0.71) | 0.362 | 0.042 (0.4) | 0.915 |
| Age | − 0.123 (0.18) | 0.487 | 0.223 (0.1) | 0.024 |
| Sex | − 0.771 (0.85) | 0.365 | − 1.42 (0.47) | 0.003 |
| Site | − 0.133 (0.3) | 0.653 | 0.105 (0.17) | 0.523 |
| Vendor | − 4.717 (2.02) | 0.02 | 0.101 (1.14) | 0.929 |
The model controls for age, sex, site, and vendor. Significant values are in bold.